| Insignia Financial Ltd (IFL) ORDINARY FULLY PAID |
Financials |
$2,361 |
Change of Director's Interest Notice
|
29 Aug 2024 10:20AM |
$2.260 |
$3.520 |
risen by
55.75%
|
|
| Felix Gold Limited (FXG) ORDINARY FULLY PAID |
Materials |
$60 |
Investor Briefing Presentation
|
29 Aug 2024 10:20AM |
$0.085 |
$0.145 |
risen by
70.59%
|
|
| Insignia Financial Ltd (IFL) ORDINARY FULLY PAID |
Financials |
$2,361 |
Change of Director's Interest Notice
|
29 Aug 2024 10:19AM |
$2.260 |
$3.520 |
risen by
55.75%
|
|
| Clarity Pharmaceuticals Ltd (CU6) ORDINARY FULLY PAID |
Health Care |
$694 |
Application for quotation of securities - CU6
|
29 Aug 2024 10:19AM |
$6.770 |
$2.160 |
fallen by
68.09%
|
|
| Insignia Financial Ltd (IFL) ORDINARY FULLY PAID |
Financials |
$2,361 |
Change of Director's Interest Notice
|
29 Aug 2024 10:18AM |
$2.260 |
$3.520 |
risen by
55.75%
|
|
| AGL Energy Limited (AGL) ORDINARY FULLY PAID |
Utilities |
$7,097 |
Notification of cessation of securities - AGL
|
29 Aug 2024 10:16AM |
$11.395 |
$10.550 |
fallen by
7.42%
|
|
| Insignia Financial Ltd (IFL) ORDINARY FULLY PAID |
Financials |
$2,361 |
Change of Director's Interest Notice
|
29 Aug 2024 10:14AM |
$2.260 |
$3.520 |
risen by
55.75%
|
|
| Region Group (RGN) FULLY PAID UNITS STAPLED SECURITIES |
Real Estate |
$2,788 |
Taxation Components - RGN Final Distribution June 2024
|
29 Aug 2024 10:14AM |
$2.255 |
$2.400 |
risen by
6.43%
|
|
| MC Mining Limited (MCM) ORDINARY FULLY PAID |
Energy |
$57 |
Initial Director's Interest Notice
|
29 Aug 2024 10:14AM |
$0.037 |
$0.095 |
risen by
156.76%
|
|
| Insignia Financial Ltd (IFL) ORDINARY FULLY PAID |
Financials |
$2,361 |
Change of Director's Interest Notice
|
29 Aug 2024 10:14AM |
$2.260 |
$3.520 |
risen by
55.75%
|
|
| Timah Resources Limited (TML) ORDINARY FULLY PAID |
Utilities |
$3 |
Half Yearly Report and Accounts
|
29 Aug 2024 10:13AM |
$0.037 |
$0.035 |
fallen by
5.41%
|
|
TML - Price-sensitive ASX Announcement
Full Release
Key Points
- Timah Resources Limited (TML) provided a half-yearly report for the period ending 31 December 2023.
- The company reported a gross profit of $71.2 million for the half-year, compared to $80.6 million for the previous year.
- Revenue for the half-year was $374.4 million, primarily from gold and other metal sales.
- Cost of sales amounted to $303.2 million, with significant expenditures in exploration, evaluation, and development.
- The net profit after tax for the period was $49.7 million, showing an increase from $30.8 million for the previous year.
- Total assets of the company increased significantly due to the acquisition of investments, particularly in Red 5 shares.
- The company holds substantial mineral reserves and resources across various projects, including Deflector and Rothsay.
- The report includes audited financial statements with unqualified opinions from KPMG.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Insignia Financial Ltd (IFL) ORDINARY FULLY PAID |
Financials |
$2,361 |
Change of Director's Interest Notice
|
29 Aug 2024 10:12AM |
$2.260 |
$3.520 |
risen by
55.75%
|
|
| WAM Alternative Assets Limited (WMA) ORDINARY FULLY PAID |
Financials |
$193 |
WAM Alternative Assets increases fully franked full year div
|
29 Aug 2024 10:10AM |
$0.985 |
$0.980 |
fallen by
0.51%
|
|
| Asaplus Resources Limited (AJY) ORDINARY FULLY PAID |
Materials |
- |
Show Cause Letter
|
29 Aug 2024 10:10AM |
$0.010 |
$0.010 |
fallen by
0%
|
|
| Airtasker Limited (ART) ORDINARY FULLY PAID |
Communication Services |
$133 |
FY24 Results Market Release
|
29 Aug 2024 10:08AM |
$0.260 |
$0.293 |
risen by
12.50%
|
|
ART - Price-sensitive ASX Announcement
Full Release
Key Points
- Airtasker achieved positive free cash flow of $1.2 million in FY24, an improvement of $8.9 million from the previous comparative period (pcp).
- Airtasker marketplaces' revenue grew by 9.8% to $38.1 million.
- The UK marketplace saw a substantial revenue growth of 76.3% in 4Q24.
- As of 30 June 2024, Airtasker had $17.8 million in cash and term deposits.
- Airtasker secured $11.0 million in Australian advertising inventory from oOh!media and ARN Media.
- Employee expenses were reduced by 26.1% to $22.4 million.
- Technology, general, and administrative expenses decreased by 16.4% to $10.7 million.
- EBITDA improved by 97.8% to a loss of $0.2 million.
- Completed tasks reached a record number due to improved marketplace reliability and a decline of 26.3% in cancellations.
- Airtasker’s Australian marketplaces generated $31.0 million EBITDA, enabling investment in new marketplaces.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vection Technologies Ltd (VR1) ORDINARY FULLY PAID |
Information Technology |
$39 |
Generative AI Company Acquisition Presentation
|
29 Aug 2024 10:06AM |
$0.013 |
$0.022 |
risen by
69.23%
|
|
VR1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Vection Technologies is acquiring The Digital Box to enhance AI capabilities.
- The acquisition aims to improve human-machine interactions across various sectors using AI.
- The combined portfolio will include hardware, software, VR, and AR solutions.
- The Digital Box specializes in AI avatars and has strong integrations with OpenAI.
- The acquisition will add approximately $10m in revenue and $1m in EBITDA for Vection.
- Former Apple COO Marco Landi will join Vection’s board.
- The acquisition aims to capitalize on opportunities in healthcare, retail, space economy, gaming, and real estate.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WAM Capital Limited (WAM) ORDINARY FULLY PAID |
Financials |
$1,746 |
Appendix 4E and Annual Report
|
29 Aug 2024 10:06AM |
$1.540 |
$1.550 |
risen by
0.65%
|
|
WAM - Price-sensitive ASX Announcement
Full Release
Key Points
- WAM Capital Limited's financial position and performance for the year ended June 30, 2024 is detailed.
- The audit was conducted in accordance with Australian Auditing Standards and the company complied with relevant ethical requirements.
- Key audit matters include the existence and valuation of financial assets and the accuracy of management and performance fees.
- The company’s investments are based on observable data from the ASX and other markets.
- Control and valuation processes were evaluated and confirmed by the audit.
- The remuneration report for WAM Capital Limited for the year ended June 30, 2024 complies with the Corporations Act 2001.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Civmec Limited (CVL) ORDINARY FULLY PAID |
Industrials |
$554 |
Update on Approval Application
|
29 Aug 2024 10:06AM |
$1.090 |
$1.090 |
fallen by
0%
|
|
| Saunders International Limited (SND) ORDINARY FULLY PAID |
Industrials |
$88 |
Resignation of Company Secretary
|
29 Aug 2024 10:05AM |
$0.820 |
$0.720 |
fallen by
12.20%
|
|
| Airtasker Limited (ART) ORDINARY FULLY PAID |
Communication Services |
$133 |
FY24 Full Year Statutory Accounts
|
29 Aug 2024 10:05AM |
$0.260 |
$0.293 |
risen by
12.50%
|
|
ART - Price-sensitive ASX Announcement
Full Release
Key Points
- Airtasker Limited has issued ordinary shares amounting to 452,498,074 fully paid shares as of 30 June 2024.
- Unclaimed customer credits amounted to $2,894,000 for FY24, down from $4,607,000 in the previous year.
- Various shares under rights and options were issued throughout the year, with detailed movements and issue dates listed.
- The company's revenue recognition policy for unclaimed customer credits includes customer redemption or expiration, with an 18-month expected realization period.
- The directors' report and notes to the consolidated financial statements include detailed financial data and explanations for the year ended 30 June 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Raiz Invest Limited (RZI) ORDINARY FULLY PAID |
Financials |
$65 |
Application for quotation of securities - RZI
|
29 Aug 2024 10:05AM |
$0.390 |
$0.615 |
risen by
57.69%
|
|
| Acrux Limited (ACR) ORDINARY FULLY PAID |
Health Care |
$9 |
Investor Webinar Information - FY24 Results
|
29 Aug 2024 10:03AM |
$0.060 |
$0.022 |
fallen by
63.33%
|
|
| Aeeris Ltd (AER) ORDINARY FULLY PAID |
Communication Services |
$5 |
Appendix 4G & Corporate Governance Statement
|
29 Aug 2024 10:03AM |
$0.096 |
$0.068 |
fallen by
29.17%
|
|
| Dundas Minerals Limited (DUN) ORDINARY FULLY PAID |
Materials |
$2 |
Cleansing Notice - Issue of Securities
|
29 Aug 2024 10:02AM |
$0.035 |
$0.017 |
fallen by
51.43%
|
|
| Acrux Limited (ACR) ORDINARY FULLY PAID |
Health Care |
$9 |
FY24 Full Year Results - Investor Presentation
|
29 Aug 2024 10:02AM |
$0.060 |
$0.022 |
fallen by
63.33%
|
|
ACR - Price-sensitive ASX Announcement
Full Release
Key Points
- Acrux is a leader in the development of topically applied prescription pharmaceutical products.
- The company has a 25+ year track record with US NDA, US ANDA, and EMA product approvals.
- Acrux has a network of CDMO for development, scale-up, and commercial manufacturing.
- The company has commercial licensees in over 40 countries.
- Acrux focuses on an underserved market segment in the United States.
- As of the presentation, Acrux has 7 topical prescription products under development.
- Dapsone 5% Gel and Prilocaine/Lidocaine Cream were recently launched in the United States.
- Acrux aims to develop a diversified, on-market portfolio of products generating sustainable revenue streams.
- The company has expertise in regulatory submissions and commercial product launches.
- FDA approval of 5 products since 2021 with 2 recent launches in the United States.
- Market size for topically applied drugs in the US is approximately $16bn.
- Acrux has a TGA approved GMP facility and specialized scientists for development and regulatory submission.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
